Brigitte Staggl

Brigitte Staggl is a prominent inventor based in Kundl, Austria. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds and methods for treating bacterial infections. With a total of 2 patents to her name, her work has the potential to impact the medical community positively.

Latest Patents

Staggl's latest patents include groundbreaking inventions that focus on avibactam free acid and its sodium salt. The first patent describes avibactam free acid, detailing a method for its preparation and a pharmaceutical composition that includes this compound. This composition is designed for the treatment and prevention of bacterial infections, showcasing her commitment to addressing critical health challenges. The second patent outlines a process for preparing crystalline form C of avibactam sodium, emphasizing the importance of specific conditions such as low water content and elevated temperatures to achieve the desired polymorphic form.

Career Highlights

Brigitte Staggl is currently employed at Sandoz AG, a global leader in generic pharmaceuticals. Her role at the company allows her to leverage her expertise in pharmaceutical chemistry to develop innovative solutions that meet the needs of healthcare providers and patients alike.

Collaborations

Throughout her career, Staggl has collaborated with notable colleagues, including Michael Fischer and Andreas Lechner. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Brigitte Staggl's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as an influential inventor in the field. Her work continues to pave the way for new treatments that can significantly improve patient outcomes.

Profile summary based on public USPTO records.